630 related articles for article (PubMed ID: 17353249)
21. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
Denis O; Deplano A; Nonhoff C; Hallin M; De Ryck R; Vanhoof R; De Mendonça R; Struelens MJ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2680-5. PubMed ID: 16870758
[TBL] [Abstract][Full Text] [Related]
22. Optimizing therapy for MRSA pneumonia.
Skrupky LP; Micek ST; Kollef MH
Semin Respir Crit Care Med; 2007 Dec; 28(6):615-23. PubMed ID: 18095225
[TBL] [Abstract][Full Text] [Related]
23. Vancomycin-resistant Enterococcus spp.: validation of susceptibility testing and in vitro activity of vancomycin, linezolid, tigecycline and daptomycin.
Rathe M; Kristensen L; Ellermann-Eriksen S; Thomsen MK; Schumacher H
APMIS; 2010 Jan; 118(1):66-73. PubMed ID: 20041873
[TBL] [Abstract][Full Text] [Related]
24. Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin.
Castagnola E; Bandettini R; Lorenzi I; Caviglia I; Macrina G; Tacchella A
Pediatr Infect Dis J; 2010 Nov; 29(11):1047-8. PubMed ID: 20581735
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms.
Holmberg A; Rasmussen M
Int J Antimicrob Agents; 2014 Jul; 44(1):78-80. PubMed ID: 24837415
[TBL] [Abstract][Full Text] [Related]
26. In vitro activities of daptomycin, tigecycline, linezolid and eight other antibiotics, alone and in combination, against 41 Staphylococcus spp. clinical isolates from bone and joint infections.
Kuli B; de Barbeyrac B; Dauchy FA; Dutronc H; Bébéar C; Mégraud F; Dupon M
Int J Antimicrob Agents; 2009 May; 33(5):491-3. PubMed ID: 19153031
[No Abstract] [Full Text] [Related]
27. Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.
Dowzicky MJ; Chmelařová E
Int J Antimicrob Agents; 2011 Jun; 37(6):562-6. PubMed ID: 21497066
[TBL] [Abstract][Full Text] [Related]
28. Treatment of infections caused by resistant Staphylococcus aureus.
Anstead GM; Quinones-Nazario G; Lewis JS
Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of tigecycline and vancomycin activities in an in vitro biofilm model generated with methicillin-resistant Staphylococcus aureus].
Aslan H; Yapar N
Mikrobiyol Bul; 2015 Oct; 49(4):475-83. PubMed ID: 26649405
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains.
Kaya O; Akcam FZ; Temel EN
Microb Drug Resist; 2008 Jun; 14(2):151-3. PubMed ID: 18494600
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
Cesur S; Irmak H; Simşek H; Cöplü N; Kılıç H; Arslan U; Bayramoğlu G; Baysan BO; Gülay Z; Hoşoğlu S; Berktaş M; Gencer S; Demiröz AP; Esen B; Karabiber N; Aydın F; Yalçın AN
Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
[TBL] [Abstract][Full Text] [Related]
33. Activity of ceftaroline against extracellular (broth) and intracellular (THP-1 monocytes) forms of methicillin-resistant Staphylococcus aureus: comparison with vancomycin, linezolid and daptomycin.
Mélard A; Garcia LG; Das D; Rozenberg R; Tulkens PM; Van Bambeke F; Lemaire S
J Antimicrob Chemother; 2013 Mar; 68(3):648-58. PubMed ID: 23188792
[TBL] [Abstract][Full Text] [Related]
34. In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea.
Cha JO; Park YK; Lee YS; Chung GT
Diagn Microbiol Infect Dis; 2011 May; 70(1):112-8. PubMed ID: 21398072
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
J Infect; 2011 Sep; 63(3):229-35. PubMed ID: 21763722
[TBL] [Abstract][Full Text] [Related]
36. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
37. Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Rodríguez-Vidigal FF; Vera Tomé A; Robles Marcos M
Rev Esp Quimioter; 2011 Jun; 24(2):74-8. PubMed ID: 21666998
[TBL] [Abstract][Full Text] [Related]
38. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
39. In vitro efficacies and resistance profiles of rifampin-based combination regimens for biofilm-embedded methicillin-resistant Staphylococcus aureus.
Tang HJ; Chen CC; Cheng KC; Wu KY; Lin YC; Zhang CC; Weng TC; Yu WL; Chiu YH; Toh HS; Chiang SR; Su BA; Ko WC; Chuang YC
Antimicrob Agents Chemother; 2013 Nov; 57(11):5717-20. PubMed ID: 23959320
[TBL] [Abstract][Full Text] [Related]
40. Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.
Tsai HY; Liao CH; Chen YH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
Antimicrob Agents Chemother; 2012 Jun; 56(6):3402-5. PubMed ID: 22491684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
